Skip to content

Clinical Value of Metabolomics in Early Diagnosis and Prognostic Assessment of Sepsis

Clinical Value of Metabolomics in Early Diagnosis and Prognostic Assessment of Sepsis

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600129247
Enrollment
Unknown
Registered
2026-08-01
Start date
2026-08-01
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sepsis

Interventions

sepsis group:None

Sponsors

Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1.Patients aged = 18 years who were admitted to SICU due to perioperative factors; 2.Suspected or confirmed infection with an acute increase of >= 2 points in SOFA score compared to baseline, blood culture, blood routine, serum procalcitonin (PCT), C-reactive protein (CRP) and other tests should be performed according to standard operating procedures. 3.Voluntary signing of informed consent form;

Exclusion criteria

Exclusion criteria: 1.Patients who refuse the trial; 2.Various reasons led to incomplete data collection in the end; 3.Patients with central hyperthermia, malignant hematological diseases and advanced or recent malignant tumors who have been treated with chemotherapy and immunosuppressive drugs, and patients with basic diseases such as diabetes, hyperlipidemia, liver and kidney metabolic abnormalities, have been definitely diagnosed;

Design outcomes

Primary

MeasureTime frame
Metabolites;

Countries

China

Contacts

Public ContactMao Yanfei

Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine

maoyanfei1979@163.com+86 21 25078999

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Aug 10, 2026